{"id":"W4414267265","doi":"10.1016/j.vaccine.2025.127748","title":"Safety and immunogenicity of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in healthy adults; a randomized controlled first-in-human dose-escalation trial","year":2025,"lang":"en","type":"article","venue":"Vaccine","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Nexen (Canada); Nova Scotia Health Authority; Dalhousie University; University of Saskatchewan","funders":"Government of Saskatchewan; Canada Foundation for Innovation; Western Economic Diversification Canada; Coalition for Epidemic Preparedness Innovations; Innovation Saskatchewan; Ministry of Agriculture - Saskatchewan","keywords":"Immunogenicity; Antibody; Recombinant DNA; Antibody response; Neutralizing antibody; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003029322,0.001624255,0.002069648,0.0003415218,0.0004330523,0.001068036,0.0007288005,0.002129146,0.003013928],"category_scores_gemma":[0.002262498,0.0007019563,0.001275677,0.0003014544,0.0009174534,0.0009117641,0.0003010822,0.002218616,0.000647851],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006411289,"about_ca_system_score_gemma":0.001215011,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004654391,"about_ca_topic_score_gemma":0.0006743624,"domain_scores_codex":[0.9989127,0.0005862341,0.0000714479,0.0002019212,0.0001003783,0.0001273437],"domain_scores_gemma":[0.9984766,0.0003337953,0.0005234531,0.0001216006,0.0001547417,0.0003898025],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9753628,0.009286672,0.001323812,0.000406109,0.0005582796,0.00002496894,0.00006346133,0.0002081736,0.003850105,0.00003431739,0.0004329848,0.008448309],"study_design_scores_gemma":[0.8230957,0.1712693,0.003503219,0.00002897936,0.0003871495,0.00003218776,0.0000179185,0.0002877759,0.0008493268,0.00006662917,0.0004492606,0.00001253427],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9932786,0.001952969,0.0003467074,0.0002491975,0.0001750293,0.002738973,0.0005571441,0.00005048728,0.0006510408],"genre_scores_gemma":[0.9920363,0.001219137,0.0008734423,0.0005558557,0.0002910983,0.003450072,0.0005927706,0.00001284102,0.0009685941],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003029322,"threshold_uncertainty_score":0.01602077,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01834761746794434,"score_gpt":0.3365299450197043,"score_spread":0.31818232755176,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}